Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03371225 |
Recruitment Status :
Recruiting
First Posted : December 13, 2017
Last Update Posted : January 18, 2023
|
Sponsor:
Spaulding Rehabilitation Hospital
Information provided by (Responsible Party):
Felipe Fregni, MD, PhD, MPH, Spaulding Rehabilitation Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | September 30, 2024 |
Estimated Study Completion Date : | September 14, 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):